PERINATOLOGIYA I PEDIATRIYA.2015.2(62):52-55

The clinical experience with the drug «Furasol» (powder for solution for rinsing) production of JSC «Olainfarm / JSC “Olainfarm”» (Latvia) in the treatment of exacerbations of chronic tonsillitis and / or pharyngitis in children

Kvashnina L. V., Rodionov V. P.

SI «Institute of Pediatrics, Gynecology and Obstetrics NAMS of Ukraine», Kyiv, Ukraine

Purpose — to improve the effectiveness of the treatment of inflammatory diseases of the nasopharynx (exacerbations of chronic faringotonzillita) in children by topical medications furagin soluble (drug «Furasol»).

Patients and methods. A study of the microbial spectrum of the nasopharynx and the general analysis of blood from 20 children of different ages, with exacerbation of chronic faringotonzillita, under the influence of local monotherapy furagin soluble (drug «Furasol»).

Results. It was found that the aggravation of chronic tonsillitis and / or pharyngitis in children is most often caused by microbial associations Gram-negative and Gram-positive microorganisms. Eradication of pathogens and contributes to normalization microbiocenosis nasal drug «Furasol» which, in the absence of collateral, toxic and alergiziruyuschego action has expressed anti-microbial and anti-inflammatory properties comparable to or exceeding the in vitro effect of antibiotics.

The conclusions regarding the prospects for the use of furasola prevention of exacerbations in children with chronic pathology of throat and sickly children to carry out preventive measures during seasonal outbreaks of SARS.

Key words: children, inflammatory diseases of the nasopharynx, nasal microbiocenosis, nitrofurans, the drug «Furasol».